-
Je něco špatně v tomto záznamu ?
Telemedicine maintains good glucose control in children with type 1 diabetes but is not time saving for healthcare professionals: KITES randomized study
L. Plachy, V. Neuman, K. Velichova, MG. Slavenko, A. Santova, S. Anne Amaratunga, B. Obermannova, S. Kolouskova, S. Pruhova, Z. Sumnik, L. Petruzelkova
Jazyk angličtina Země Irsko
Typ dokumentu randomizované kontrolované studie, časopisecké články
Odkazy
PubMed
38437986
DOI
10.1016/j.diabres.2024.111602
Knihovny.cz E-zdroje
- MeSH
- diabetes mellitus 1. typu * MeSH
- dítě MeSH
- glykovaný hemoglobin MeSH
- hypoglykemika MeSH
- krevní glukóza MeSH
- lidé MeSH
- selfmonitoring glykemie MeSH
- telemedicína * MeSH
- Check Tag
- dítě MeSH
- lidé MeSH
- Publikační typ
- časopisecké články MeSH
- randomizované kontrolované studie MeSH
AIMS: To evaluate glucose control non-inferiority and time benefits of telemedicine follow-up in children with type 1 diabetes (CwD). METHODS: In a single-center 9-month-long randomized controlled study (clinicaltrials.gov NCT05484427), 50 children were randomized to either telemedicine group (TG) followed-up distantly by e-mail, or to face-to-face group (FFG) attending standard personal visits. The primary endpoint was non-inferiority of HbA1c at final visit (level of non-inferiority was set at 5 mmol/mol). The secondary endpoints were subcutaneous glucose monitoring parameters and time consumption from both study subjects' and the physicians' point of view. RESULTS: Non-inferiority of HbA1c in the TG was proven (mean HbA1C 45.8 ± 7.3 [TG] vs. 50.0 ± 12.6 [FFG] mmol/mol, 6.3 vs. 6.7 % DCCT, p = 0.17; between groups HbA1C difference 95 % CI -10.2 to 1.9 mmol/mol). Telemedicine saved time for participants (mean visit duration [MVD] 50 [TG] vs. 247 min [FFG], p < 0.001). There were no other differences between groups neither in CGM parameters nor physician's time consumption (MVD 19 [TG] vs. 20 min [FFG], p = 0.58). CONCLUSIONS: Nine-month telemedicine follow-up of the children with well-controlled T1D is not inferior to standard face-to-face visits. Telemedicine visits saved time for the participants but not for their diabetologists.
- 000
- 00000naa a2200000 a 4500
- 001
- bmc24006836
- 003
- CZ-PrNML
- 005
- 20240423155527.0
- 007
- ta
- 008
- 240412e20240302ie f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1016/j.diabres.2024.111602 $2 doi
- 035 __
- $a (PubMed)38437986
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a ie
- 100 1_
- $a Plachy, Lukas $u Department of Pediatrics of Second Faculty of Medicine, Charles University in Prague and Motol University Hospital, V Uvalu 84, Prague, 15000, Czech Republic. Electronic address: lukas.plachy@fnmotol.cz
- 245 10
- $a Telemedicine maintains good glucose control in children with type 1 diabetes but is not time saving for healthcare professionals: KITES randomized study / $c L. Plachy, V. Neuman, K. Velichova, MG. Slavenko, A. Santova, S. Anne Amaratunga, B. Obermannova, S. Kolouskova, S. Pruhova, Z. Sumnik, L. Petruzelkova
- 520 9_
- $a AIMS: To evaluate glucose control non-inferiority and time benefits of telemedicine follow-up in children with type 1 diabetes (CwD). METHODS: In a single-center 9-month-long randomized controlled study (clinicaltrials.gov NCT05484427), 50 children were randomized to either telemedicine group (TG) followed-up distantly by e-mail, or to face-to-face group (FFG) attending standard personal visits. The primary endpoint was non-inferiority of HbA1c at final visit (level of non-inferiority was set at 5 mmol/mol). The secondary endpoints were subcutaneous glucose monitoring parameters and time consumption from both study subjects' and the physicians' point of view. RESULTS: Non-inferiority of HbA1c in the TG was proven (mean HbA1C 45.8 ± 7.3 [TG] vs. 50.0 ± 12.6 [FFG] mmol/mol, 6.3 vs. 6.7 % DCCT, p = 0.17; between groups HbA1C difference 95 % CI -10.2 to 1.9 mmol/mol). Telemedicine saved time for participants (mean visit duration [MVD] 50 [TG] vs. 247 min [FFG], p < 0.001). There were no other differences between groups neither in CGM parameters nor physician's time consumption (MVD 19 [TG] vs. 20 min [FFG], p = 0.58). CONCLUSIONS: Nine-month telemedicine follow-up of the children with well-controlled T1D is not inferior to standard face-to-face visits. Telemedicine visits saved time for the participants but not for their diabetologists.
- 650 _2
- $a dítě $7 D002648
- 650 _2
- $a lidé $7 D006801
- 650 12
- $a diabetes mellitus 1. typu $7 D003922
- 650 _2
- $a krevní glukóza $7 D001786
- 650 _2
- $a glykovaný hemoglobin $7 D006442
- 650 _2
- $a selfmonitoring glykemie $7 D015190
- 650 12
- $a telemedicína $7 D017216
- 650 _2
- $a hypoglykemika $7 D007004
- 655 _2
- $a randomizované kontrolované studie $7 D016449
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Neuman, Vit $u Department of Pediatrics of Second Faculty of Medicine, Charles University in Prague and Motol University Hospital, V Uvalu 84, Prague, 15000, Czech Republic. Electronic address: vit.neuman@fnmotol.cz
- 700 1_
- $a Velichova, Katerina $u Department of Pediatrics of Second Faculty of Medicine, Charles University in Prague and Motol University Hospital, V Uvalu 84, Prague, 15000, Czech Republic. Electronic address: kacka.velichova@seznam.cz
- 700 1_
- $a Slavenko, Matvei G $u Department of Pediatrics of Second Faculty of Medicine, Charles University in Prague and Motol University Hospital, V Uvalu 84, Prague, 15000, Czech Republic. Electronic address: matvei.slavenko@fnmotol.cz
- 700 1_
- $a Santova, Alzbeta $u Department of Pediatrics of Second Faculty of Medicine, Charles University in Prague and Motol University Hospital, V Uvalu 84, Prague, 15000, Czech Republic. Electronic address: alzbeta.santova@fnmotol.cz
- 700 1_
- $a Anne Amaratunga, Shenali $u Department of Pediatrics of Second Faculty of Medicine, Charles University in Prague and Motol University Hospital, V Uvalu 84, Prague, 15000, Czech Republic. Electronic address: shanali.amaratunga@fnmotol.cz
- 700 1_
- $a Obermannova, Barbora $u Department of Pediatrics of Second Faculty of Medicine, Charles University in Prague and Motol University Hospital, V Uvalu 84, Prague, 15000, Czech Republic. Electronic address: barbora.obermannova@fnmotol.cz
- 700 1_
- $a Kolouskova, Stanislava $u Department of Pediatrics of Second Faculty of Medicine, Charles University in Prague and Motol University Hospital, V Uvalu 84, Prague, 15000, Czech Republic. Electronic address: stepanka.pruhova@lfmotol.cuni.cz
- 700 1_
- $a Pruhova, Stepanka $u Department of Pediatrics of Second Faculty of Medicine, Charles University in Prague and Motol University Hospital, V Uvalu 84, Prague, 15000, Czech Republic. Electronic address: stanislava.kolouskova@lfmotol.cuni.cz
- 700 1_
- $a Sumnik, Zdenek $u Department of Pediatrics of Second Faculty of Medicine, Charles University in Prague and Motol University Hospital, V Uvalu 84, Prague, 15000, Czech Republic. Electronic address: zdenek.sumnik@lfmotol.cuni.cz
- 700 1_
- $a Petruzelkova, Lenka $u Department of Pediatrics of Second Faculty of Medicine, Charles University in Prague and Motol University Hospital, V Uvalu 84, Prague, 15000, Czech Republic
- 773 0_
- $w MED00001385 $t Diabetes research and clinical practice $x 1872-8227 $g Roč. 209 (20240302), s. 111602
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/38437986 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y - $z 0
- 990 __
- $a 20240412 $b ABA008
- 991 __
- $a 20240423155523 $b ABA008
- 999 __
- $a ok $b bmc $g 2081047 $s 1216603
- BAS __
- $a 3
- BAS __
- $a PreBMC-MEDLINE
- BMC __
- $a 2024 $b 209 $c - $d 111602 $e 20240302 $i 1872-8227 $m Diabetes research and clinical practice $n Diabetes Res Clin Pract $x MED00001385
- LZP __
- $a Pubmed-20240412